Susan L. Coultas, Ph.D.
Dr. Coultas has served as our Chief Clinical Officer since June 2022, bringing 35 years of experience in clinical development in the biopharmaceutical industry. As Chief Clinical Officer, she is responsible for clinical operational planning and management oversight of the initiation and execution of all Clearside clinical trials as well as interactions with the FDA and international health authorities regarding all clinical trials.
Most recently, Dr. Coultas served as Senior Vice President of Clinical Development at Kala Pharmaceuticals, where she was responsible for the planning and execution of its clinical programs, resulting in two new drug application filings and product approvals. Dr. Coultas has worked with multiple ophthalmic companies, both internally and as a consultant, including Alcon Laboratories, Inc., CibaVision Ophthalmics, Sucampo Pharmaceuticals, and Bausch+Lomb, Inc. Earlier in her career, as owner of InfoQuest Clinical Network, Inc., Dr. Coultas successfully identified, developed, and led a large network of clinical research professionals that managed numerous clinical trials in multiple systemic and ophthalmic therapeutic areas. Dr. Coultas earned a Ph.D. in Public Health, Epidemiology, from Walden University, a M.S. in Biology from University of North Texas, and a B.S. in Biology from Texas Wesleyan University.